Literature DB >> 3895929

Noonan syndrome: a review.

H M Mendez, J M Opitz.   

Abstract

After an introduction dealing with the "historical evolution" of the Noonan syndrome (NS), we try to define the NS phenotype based on clinical descriptions published since 1883. The theories concerning the cause of the NS are discussed fully. The peculiar cardiac involvement deserves special attention and raises the question of whether the Watson and LEOPARD syndromes are indistinguishable from NS. Finally, the recent contributions to the variability of the NS phenotype (reports on lymphatic dysplasia, partial deficiency of factor XI, malignant hyperthermia, perceptual-motor disabilities, and endocrine evaluation) are also described.

Entities:  

Mesh:

Year:  1985        PMID: 3895929     DOI: 10.1002/ajmg.1320210312

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  74 in total

1.  Absence of linkage of Noonan syndrome to the neurofibromatosis type 1 locus.

Authors:  M Sharland; R Taylor; M A Patton; S Jeffery
Journal:  J Med Genet       Date:  1992-03       Impact factor: 6.318

2.  A clinical study of Noonan syndrome.

Authors:  M Sharland; M Burch; W M McKenna; M A Paton
Journal:  Arch Dis Child       Date:  1992-02       Impact factor: 3.791

3.  Coarctation of the aorta and renal hypoplasia in a boy with Turner/Noonan surface anomalies and a 46,XY karyotype: a clinical model for the possible impairment of a putative lymphogenic gene(s) for Turner somatic stigmata.

Authors:  T Hasegawa; T Ogata; Y Hasegawa; M Honda; T Nagai; Y Fukushima; Y Nakahori; N Matsuo
Journal:  Hum Genet       Date:  1996-05       Impact factor: 4.132

Review 4.  Genetic Basis for Congenital Heart Disease: Revisited: A Scientific Statement From the American Heart Association.

Authors:  Mary Ella Pierpont; Martina Brueckner; Wendy K Chung; Vidu Garg; Ronald V Lacro; Amy L McGuire; Seema Mital; James R Priest; William T Pu; Amy Roberts; Stephanie M Ware; Bruce D Gelb; Mark W Russell
Journal:  Circulation       Date:  2018-11-20       Impact factor: 29.690

5.  Prenatal diagnosis of Noonan's syndrome in a female infant with spontaneous resolution of cystic hygroma and hydrops.

Authors:  L Izquierdo; O Kushnir; D Sanchez; L Curet; P Olney; G E Sarto; C Clericuzio; R Olney
Journal:  West J Med       Date:  1990-04

6.  Phenotypic spectrum of 80 Greek patients referred as Noonan syndrome and PTPN11 mutation analysis: the value of initial clinical assessment.

Authors:  Anna Papadopoulou; Michalis Issakidis; Evangelia Gole; Konstantina Kosma; Helen Fryssira; Andreas Fretzayas; Polyxeni Nicolaidou; Sophia Kitsiou-Tzeli
Journal:  Eur J Pediatr       Date:  2011-05-18       Impact factor: 3.183

7.  Defective growth hormone (GH) secretion and short-term treatment in Noonan syndrome.

Authors:  A T Soliman; A Rajab; M el Zalabany; I alSalmi; M A Fattah
Journal:  Indian J Pediatr       Date:  1998 Sep-Oct       Impact factor: 1.967

8.  Genotype differences in cognitive functioning in Noonan syndrome.

Authors:  E I Pierpont; M E Pierpont; N J Mendelsohn; A E Roberts; E Tworog-Dube; M S Seidenberg
Journal:  Genes Brain Behav       Date:  2008-12-11       Impact factor: 3.449

9.  Behavioural aspects and psychiatric findings in Noonan's syndrome.

Authors:  A Wood; A Massarano; M Super; R Harrington
Journal:  Arch Dis Child       Date:  1995-02       Impact factor: 3.791

10.  Noonan's and DiGeorge syndromes with monosomy 22q11.

Authors:  D I Wilson; S B Britton; C McKeown; D Kelly; I E Cross; S Strobel; P J Scambler
Journal:  Arch Dis Child       Date:  1993-02       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.